Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity


The full document isn't yet available to us from the patent office.


The invention relates to antibodies against human CD39 and use thereof for inhibiting T regulatory cells (Treg) activity. More particularly CD39 antibodies may be used for the treatment or prevention of cancers and infectious diseases.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Apr 12, 2017
  • Application: Jan 30, 2009
    EP EP 16198909 A
  • Priority: Jan 30, 2009
    EP EP 09705212 A
  • Priority: Aug 20, 2008
    EP EP 08162683 A
  • Priority: Jan 31, 2008
    EP EP 08300061 A

Download Citation

Sign in to the Lens